info@ceoworld.biz
Thursday, April 25, 2024
CEOWORLD magazine - Latest - CEO Agenda - 2 Most Powerful And Influential Women In The Pharma And Biotech 2014

CEO Agenda

2 Most Powerful And Influential Women In The Pharma And Biotech 2014

Heather Bresch

Two powerful Women leaders in Pharma and Biotech, Heather Bresch and Deirdre Connelly, have been named to Fortune magazine’s annual list of 50 Most Powerful Women in Business list 2014.

1. Heather Bresch

Not surprisingly, Heather Bresch Bresch ranked as the most powerful woman in the Pharma And Biotech category by Fortune, ranked No. 31, the Chief Executive Officer of Mylan, Inc., a generic and specialty pharmaceuticals company. Bresch moved up six spot from last year’s ranking.
Magazine highlighted Connelly because she announced in July her plan to purchase Abbott’s generic-drug business for $5.3 billion.

Heather Bresch

Heather Bresch joined the biocon and generic-drug powerhouse Mylan 22 years ago as a secretary in the quality assurance department, the company had roughly $100 million in revenues. Now Mylan’s CEO, Bresch is running a business that had $7 billion in sales last year and more than 20,000. She also serves on the company’s board of directors.

2. Deirdre Connelly

Deirdre Connelly, ranked No. 39, President, North America Pharmaceuticals GlaxoSmithKline, ranked as the 2nd most powerful woman in the Biotech & Pharma category by Fortune, behind only Heather Bresch. She dropped nine spot from last year’s ranking.

Deirdre Connelly

Magazine highlighted Connelly because the GlaxoSmithKline U.S. division launched 6 new medicines last year, which helped increase revenue 2.7 percent to approximately $11.3 billion in that unit, even though overall sales for GlaxoSmithKline (GSK) declined worldwide. Deirdre Connelly is also helping guide GlaxoSmithKline through a major deal with Swiss drugmaker Novartis that would see the drug giants swap assets.


Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.

This report/news/ranking/statistics has been prepared only for general guidance on matters of interest and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, CEOWORLD magazine does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.


Copyright 2024 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz
SUBSCRIBE NEWSLETTER
CEOWORLD magazine - Latest - CEO Agenda - 2 Most Powerful And Influential Women In The Pharma And Biotech 2014
Prof. Dr. Amarendra Bhushan Dhiraj
Prof. Dr. Amarendra Bhushan Dhiraj is a publishing executive and economist who is the CEO and editor-in-chief of The CEOWORLD magazine, one of the world’s most influential and recognized global news publications. Additionally, he serves as the chair of the advisory board for the CEOWORLD magazine. He received his Ph.D. in Finance and Banking from the European Global School, Paris, France. He earned his Doctoral Degree in Chartered Accountancy from the European International University Paris, France, and a Doctorate in Business Administration from Kyiv National University of Technologies and Design (KNUTD), Ukraine. Dr. Amarendra also holds a Master of Business Administration degree in International Relations and Affairs from the American University of Athens, Alabama, United States.


Prof. Dr. Amarendra Bhushan Dhiraj is CEO and editor-in-chief of CEOWORLD magazine. You can follow him on LinkedIn, Facebook, Twitter.